Ocasa Executive and Leadership Team

Santiago Castro Piccolo, the Chief Executive Officer at Ocasa, directs the overarching strategic vision for life sciences logistics. By prioritizing cold chain integrity, the Chief Executive Officer ensures that pharmaceutical and biotechnology clients receive compliant, high-quality distribution services. Santiago Castro Piccolo architects long-term growth initiatives while maintaining strict adherence to regional regulatory standards across Latin America. The Chief Executive Officer collaborates with the board to optimize supply chain efficiency, ensuring that medical devices and temperature-sensitive materials reach destinations without compromise. Through constant evaluation of market demands, the Chief Executive Officer drives innovation in healthcare logistics. This leadership role involves balancing operational excellence with the complex requirements of the life sciences sector. Ultimately, the Chief Executive Officer secures the company's position as a premier provider of specialized distribution solutions, fostering trust among global healthcare partners through consistent, reliable, and compliant service delivery.

Maria Ramperti, the Chief Financial Officer at Ocasa, manages the fiscal health and capital allocation strategies necessary for supporting complex logistics operations. Overseeing financial planning and analysis, the Chief Financial Officer ensures that investments in cold chain infrastructure align with the company's long-term profitability goals. Maria Ramperti monitors cash flow and budgetary compliance, providing the necessary resources for maintaining stringent quality standards in pharmaceutical distribution. The Chief Financial Officer works closely with executive leadership to mitigate financial risks associated with international trade and regulatory shifts in the life sciences sector. By optimizing cost structures, the Chief Financial Officer supports the expansion of service capabilities across Latin American markets. This role requires precise oversight of financial reporting and internal controls to maintain transparency. Ultimately, the Chief Financial Officer drives sustainable growth by aligning fiscal performance with the operational demands of the healthcare and biotechnology industries.

Alejandro Onofrio, the Chief Financial Officer (US) at Ocasa, directs financial operations specifically tailored to the North American market presence. By managing cross-border fiscal strategies, the Chief Financial Officer (US) ensures that logistics services for life sciences clients remain competitive and financially viable. Alejandro Onofrio oversees the integration of regional financial data into the broader corporate framework, facilitating seamless reporting and compliance. The Chief Financial Officer (US) evaluates investment opportunities in advanced distribution technology to enhance cold chain management capabilities. Through rigorous analysis of market trends, the Chief Financial Officer (US) supports the company's mission to provide secure, compliant transport for medical devices and pharmaceuticals. This leadership role involves coordinating with international teams to streamline financial workflows and improve operational efficiency. Ultimately, the Chief Financial Officer (US) strengthens the company's financial foundation, enabling robust support for the specialized needs of the global life sciences sector.

J. Spolski, the President at Ocasa, oversees the execution of core logistics services and operational workflows. By focusing on the daily management of pharmaceutical distribution, the President ensures that every shipment meets the highest quality standards required for life sciences materials. J. Spolski directs the implementation of cold chain protocols, guaranteeing that temperature-sensitive products maintain integrity throughout the entire supply chain. The President coordinates with department heads to optimize resource allocation and improve service delivery speed across diverse geographic regions. Through active management of operational teams, the President drives efficiency and maintains compliance with strict regulatory frameworks. This leadership role involves fostering a culture of precision and reliability, essential for handling sensitive healthcare materials. Ultimately, the President supports the company's market impact by ensuring that operational excellence remains the cornerstone of every client engagement within the biotechnology and pharmaceutical industries.

Rolando del Rio, the President at Ocasa, manages the strategic expansion of logistics networks and infrastructure development. By focusing on the modernization of distribution centers, the President ensures that the company possesses the capacity to handle complex medical device shipments. Rolando del Rio directs the integration of advanced tracking technologies, providing clients with real-time visibility into the status of temperature-sensitive pharmaceuticals. The President collaborates with regional managers to refine supply chain processes, ensuring that operations remain agile in response to shifting market demands. Through the oversight of large-scale logistics projects, the President drives improvements in service reliability and safety. This leadership role involves balancing technical requirements with the need for scalable, compliant solutions in the life sciences sector. Ultimately, the President strengthens the company's operational footprint, ensuring that every logistics solution aligns with the stringent quality standards expected by healthcare and biotechnology partners.

Hernan Avruj, the President at Ocasa, leads the development of client-focused service models and business development initiatives. By identifying emerging needs within the life sciences industry, the President architects customized logistics solutions that address unique pharmaceutical and biotechnology requirements. Hernan Avruj oversees the management of key client relationships, ensuring that service delivery consistently exceeds expectations for quality and compliance. The President directs the alignment of sales and operational teams to capture new market opportunities across Latin America. Through the implementation of strategic partnerships, the President expands the company's reach and enhances the value proposition for healthcare clients. This leadership role involves analyzing industry trends to anticipate future logistics challenges and opportunities. Ultimately, the President drives revenue growth and market penetration by positioning the company as an indispensable partner for organizations requiring secure, specialized, and highly regulated distribution services for sensitive healthcare materials.